Wednesday June 28, 2017 03:43
Food and Healthcare Press Releases
Wuttisak Group's direction is to indicating to be a beauty and wellness Asia's leader, expanding by franchise system and there are now morethan 50 prospect franchise units. Wuttisak Group makes the business clearly defined and bring out the strength of
Singapore and regional healthcare leaders will gather at HIMSS AsiaPac17 from 11 – 14 September at the Marina Bay Sands. Themed Team-Based Care: Unifying Patients and Providers , Guest of Honour Senior Minister of State Chee Hong Tat, Ministry of Information & Communication and Ministry of Health Singapore, will give the opening address on 12 September.
To-date, the event has attracted 35+ VIP guests , the support of more than 20 regional organizations and five key sponsors. World-leading keynote speakers are also anticipated in a five-track program curated by a diverse organizing committee comprising of regional leaders.
Adj. A/Prof. Gamaliel Tan, Chief Medical Informatics Officer, JurongHealth and Chair of the HIMSS AsiaPac17 Organizing Committee said, "2017 is shaping up to be the landmark year in Singapore's progress towards its Healthcare 2020 masterplan. To enhance the accessibility, quality and affordability of care, its six public clusters will be integrated into three and a new polyclinic group, National University Polyclinic (NUP) has been formed to better integrate primary care with acute care. The three clusters: National University Health System (NUHS), SingHealth and the National Healthcare Group (NHG), are HIMSS AsiaPac17 supporting organizations which means this
- The 8-year follow-up results of a randomized phase 3 multicenter trial in adult patients with hematologic malignancies clearly showed more favorable results in the Grafalon(R) group - Severe GvHD-free and relapse-free survival was 34% in the
อันฟอร์ส เรย์เซฟ (Unfors RaySafe) ผู้นำระดับโลกด้านโซลูชั่นการรับประกันคุณภาพเอกซเรย์ ประกาศเปิดตัวผลิตภัณฑ์ RaySafe Pro-Slit Phantom และ RaySafe Pro-Stand รูปภาพ - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg RaySafe
Unfors RaySafe, the global leader of X-ray quality assurance solutions introduces the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand. Photo - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg The RaySafe Pro-Slit Phantom
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life science researchers and healthcare providers in the growing market. QIAGEN also announced
Swiss technology company Berlinger Special AG has developed a totally new generation of the security bottles which it supplies for anti-doping testing worldwide over the past few months. The new "BEREG-KIT Geneva" security bottles are currently being
LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-13[1], which plays an important role in
- Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR - Similar patents pending in other countries; anticipate favorable outcomes , a leading science and technology company, today
- Austria-based Croma-Pharma forms Joint Venture with Sihuan Pharmaceutical to market premium Intradermal-Filler in China, Hong Kong and Macao The registration of Princess(R) VOLUME and the signed Joint Venture open the fastest growing market for
Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI) that enables communication with patients who suffer from locked-in syndrome (LIS), complete locked-in
Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza(R) (liraglutide) resulted in similar reductions in the risk of major cardiovascular events in people with type 2 diabetes at high CV
Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba(R) (insulin degludec injection 100 U/mL) and insulin glargine U100, in adults
Tianjiao Zhang is one of the best dancers in China. Despite her profound hearing loss, the 20-year-old artist is dancing at the highest level, and her moving story has been showcased by the Sonova Group : an emotional portrait in film about the young
This week at the American Diabetes Association 77th Scientific Sessions, data were presented from three studies that assessed the accuracy and analytical performance of blood glucose monitoring systems (BGMS) and continuous glucose monitoring (CGM)
Findings from the real-world study, EU-TREAT (EUropean TREsiba AudiT), were presented today at the American Diabetes Association's 77th Scientific Sessions (ADA) in San Diego, US. The study showed that people with type 1 diabetes and type 2 diabetes
Ascensia Diabetes Care and Voluntis today announced a global technology partnership designed to help improve the lives of people with Type 2 diabetes by optimizing insulin management. This collaboration will connect the Voluntis basal insulin management
Ascensia Diabetes Care ประกาศในวันนี้ว่า บริษัทเป็นพันธมิตรเชิงกลยุทธ์ผ่านการทำข้อตกลงพัฒนาร่วมกับ Insulet Corporation (NASDAQ: PODD) ผู้นำด้านเทคโนโลยีอินซูลินปั๊มแบบไร้ท่อ [https://www.myomnipod.com/explore-omnipod/omnipod-system ] และระบบ Omnipod(R)
Ascensia Diabetes Care today announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump [https://www.myomnipod.com/explore-omnipod/omnipod-system ]
Ganeden, already known as a leader in probiotic technology, has used its patented probiotic strain to develop an immune health ingredient: Staimune(TM). The new ingredient utilizes the cells of the probiotic GanedenBC30(R) to support immune health, at
In the lawsuit between the plaintiff, Contergan (thalidomide) victim Andreas Meyer, and the defendant and former Board member of the Contergan Foundation, Attorney Karl Schucht, the Bonn Regional Court came to a judgement on 10.5.2017. The judgement is
Aging Readiness and Competitiveness (ARC) Report Looks at Challenges, Opportunities Presented by Massive Growth of Age-60-Plus Population Globally and Ways 12 Nations Are Addressing Them A comprehensive new report, released today by AARP, examines the
Final Results of SIRveNIB Study presented at 2017 American Society of ClinicalOncology Meeting For the second time in less than two months, a major head-to-head study has shown that SIR-Spheres Y-90 resin microspheres, administered once directly to the
Herbalife, a global nutrition company, in collaboration with the Department of Home Economics, Faculty of Agriculture, Kasetsart University, recently sponsored an academic seminar on the topic "Advances in Metabolic Syndrome". Over 140 participants